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Ischemia postconditioning (IpostC) is an effective way to alleviate ischemia and reperfusion injury; however, the protective effects
seem to be impaired in candidates with diabetes mellitus. To gain deep insight into this phenomenon, we explored the role of DJ-1, a
novel oncogene, that may exhibit powerful antioxidant capacity in postconditioning cardioprotection in a rat model of myocardial
ischemia reperfusion injury. Comparedwith normal group, cardiacDJ-1 was downregulated in diabetes. Larger postischemic infarct
size as well as exaggeration of oxidative stress was observed, while IpostC reversed the above changes in normal but not in diabetic
rats. DJ-1 was increased after ischemia and postconditioning contributed to a further elevation; however, no alteration of DJ-1 was
documented in all subgroups of diabetic rats. Alteration of the cardioprotective PI3K/Akt signaling proteins may be responsible
for the ineffectiveness of postconditioning in diabetes. There is a positive correlation relationship between p-Akt and DJ-1 but a
negative correlation between infarct size and DJ-1, which may partially explain the interaction of DJ-1 and IpostC cardioprotection.
Our result indicates a beneficial role ofDJ-1 inmyocardial ischemia reperfusion. Downregulation of cardiacDJ-1may be responsible
for the compromised diabetic heart responsiveness to IpostC cardioprotection.
1. Introduction
Ischemic heart disease, one of the major cardiovascular
complications, is a leading cause of mortality in diabetic
disease. Large evidence showed oxidative stress induced by
hyperglycemia was the major mechanism contributing to
the development and progression of myocardial infarction in
diabetes mellitus (DM) [1]. Reperfusion therapies (coronary
artery by-pass grafting, angioplasty, stent placement, or
thrombolysis) when applied expeditiously restore coronary
flow and limit cardiac dysfunction and infarct size. How-
ever, despite this, reperfusion also elicits pathophysiological
changes responsible for more tissue injury after restoration
of blood flow due to further aggravated oxidative damage
[2]. The underlying mechanisms by which oxidative stress
exerts adverse effects in myocardial ischemia reperfusion
remain incompletely understood. Ischemic postcondition-
ing provides protective effect against ischemia/reperfusion
injuries, which is associated with a reduction in reactive
oxygen species (ROS) generation, lipid peroxidation, and
intracellular and mitochondrial Ca2+ overload [3]. Com-
pared with ischemic preconditioning, postconditioning is a
more promising approach to cardioprotection due to the
difficulty to predict the onset of myocardial ischemia in
clinical practice. Clinical data strongly supports an increased
susceptibility to myocardial ischemia-reperfusion injury in
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patients with diabetes mellitus [4]. The risk of postmyocar-
dial infarction death is increased 2- to 4-fold in diabetic
patients compared to those without diabetes [5, 6]. However,
postconditioning seems to lose its cardioprotective effect in
subjects with diabetes, while the underlying mechanism is
largely unknown.
DJ-1, which was initially discovered as a novel oncogene
and first reported in 1997 [7], extensively exists in most
rodent and human tissues, such as brain, heart, kidney,
liver, pancreas, and skeletal muscle [7]. Early studies about
DJ-1 also revealed a main dwelling in familial Parkinson’
disease. Gratifying, several latest research contributed to a
progression in understanding the role of DJ-1 in oxidation
and antioxidation. Recently, Jeong et al. [8] demonstrated by
immunohistochemical analysis that transduced cell perme-
able Tat-DJ-1 fusion proteins prevented neuronal cell death in
ischemic brain injury. Moreover, Yu et al. [9] found that sta-
ble overexpression of DJ-1 attenuated ischemia/reperfusion-
induced oxidative stress in H9C2 cells under a hypoxia
condition. All these studies suggested that DJ-1 has the
antioxidative effect. However, whether or not DJ-1 expression
was inhibited in diabetic heart remains unclear. In the present
study, we hypothesized that reduction of DJ-1 expression
aggravates ischemia reperfusion injury and attenuates the
cardioprotective effects of postconditioning in diabetes.
2. Materials and Methods
2.1. Induction of Diabetes and Myocardial Ischemic Model.
108 healthy adult male Sprague-Dawley rats (aged 12 weeks)
of SPF level weighing between 250 ± 10 g were obtained
from HUNAN SLAC JD Laboratory Animal Co. Ltd. All the
animals were randomly divided into 8 groups: normal blank
control group, diabetic blank control group, normal rats sham
operated (NS group), normal rats subjected to MI/R (NIR
group), ischemic postconditioning group (NIPO group), dia-
betic rats shamoperated (DMSgroup), diabetic rats subjected
toMI/R (DMIR group) and ischemic postconditioning group
(DMIPO group). After equilibrated to surroundings for three
days, diabeteswas induced via single intraperitoneal injection
of STZ (60mg/kg, Sigma, St. Louis, MO, USA) dissolved in
citrate buffer (0.1M, pH 4.5), while the normal rats were
injected equal volume citrate buffer alone. One week after
STZ injection, rats exhibiting hyperglycemia (blood glucose
≥ 16.7mM) were considered diabetic.
At the end of suffering DM for 12 weeks, the myocardial
ischemia-reperfusion injurymodel was established by the left
anterior descending (LAD) coronary artery occlusion. The
shamgroups (N+ S group andDM+S group) that underwent
isolation of the LAD without occlusion and the IR groups
(both N + IR group and DM + IR group) subjected to 30min
myocardial ischemia and 2 h reperfusion after the LAD had
been isolated and occluded while the IPO groups (both N +
IPO group and DM + IPO group) were subjected to 3 cycles
of 10 s occlusion/10 s reperfusion after myocardial ischemia.
2.2. Determination of Myocardial Infarct Area. The
infarction area was measured by Evans blue and 2,3,5-
Triphenyltetrazolium chloride (TTC) double staining: after
the animals were sacrificed, the ligature around the coronary
artery was reoccluded and 2mL of 0.25% Evens Blue dye was
injected into the aorta to map the normally perfused region
of the heart. The myocardial area at risk (AAR) for infarction
was delineated by the area of myocardium not dyed. The
presence of Evans blue was used to identify the area that was
not subjected to the ischemia. Rat hearts were rapidly excised
and frozen at −20∘C and then sliced into 2mm thick sections
perpendicular to the heart base-apex axis using a heart slice
chamber. The slices were incubated for 15min at 37∘C in a
phosphate-buffered 1% TTC (Sigma-Aldrich, St. Louis, MO)
solution to determine infarcted myocardium. The viable
tissue was stained red by TTC, while the infarct portion
not taking up TTC stain remained pale. Morphometric
measurements of the AAR and infarct area (IA) in each slice
were performed with a scanner (Epson, v30, Japan) and an
image analysis system (Image-Pro plus; Media Cybernetics,
Bethesda, MA). The percentage of the infarcted area from
the left ventricle (IA/LV) and the area at risk from the left
ventricle (AAR/LV) were calculated.
2.3. Biochemical Assays. Myocardial tissue was harvested and
immediately homogenized on ice in 9 volumes of ice saline.
Themyocardial homogenate was centrifuged at 4,000 rpm for
10min. The activity of Superoxide Dismutase (SOD) and the
level ofMalondialdehyde (MDA), 15-F
2t-Isoprostane (15-F2t),
and Total Antioxidant Capacity (T-AOC) in myocardial tis-
sues were measured using SOD (Jiancheng, Nanjing, China),
MDA (Jiancheng, Nanjing, China), 15-F
2t-Isoprostane (Cay-
man Chemical Company, USA), and T-AOC (Jiancheng,
Nanjing, China) assay kits according to the manufacturer’s
instructions.
2.4. Western Blot Analysis. Myocardium tissue samples
(100mg) were homogenized in lysis buffer with electric
homogenate machine, and then the homogenates were cen-
trifuged at 12,000 rpm for 15mins at 4∘C. After determining
with BCA protein assay kit (Beyotime Biotech Inc., Jiangsu,
China), the supernatants were used as protein samples. Sam-
ples containing equal amounts were separated on a 10% SDS-
polyacrylamide gel, and then proteins were transferred to
PVDF membrane. After blocked in 5% nonfat-dried milk for
1 h, membranes were incubated with rabbit anti-DJ-1 or anti-
PTEN, anti-total Akt, and anti-phospho-Akt monoclonal
antibody (1 : 1000 dilution, Cell Signaling Technology, USA)
overnight at 4∘C. Subsequently, the membranes were washed
and incubated with the corresponding fluorescent tags goat
anti-rabbit polyclonal IgG (1 : 10000 dilution, LI-COR, USA)
for 1 h at room temperature. Open the Odyssey scanner and
put the membranes facing down on the designated area
for infrared fluorescence detection on the Odyssey Imaging
Systems (LI-COR, USA). GADPH was chosen as a loading
control to further assure the same volume for all the samples.
2.5. Statistical Analysis. Mean ± SD values were calculated
to summarize all outcome measurements. One-way analysis
of variance (ANOVA) was used to compare significant
differences among the groups, followed by Newman-Keuls
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Figure 1: Shown are the area at risk from the left ventricle (AAR/LV) and infarcted area from the area at risk (IA/AAR) in percent means
± SD (𝑛 = 6 each). The blue-stained areas represent nonischemic tissue, and red stained areas represent the area at risk. Pale areas indicate
infarct areas. (a) AAR/LV of normal and diabetic heart suffering from MI/R. There was no significant difference in AAR/LV between the
four groups (𝑃 > 0.05). (b) IA/AAR of normal and diabetic heart which was subjected to MI/R with or without ischemic postconditioning.
∗
𝑃 < 0.05 & ∗∗𝑃 < 0.01 versus N + IR group; no difference between DM + IR group and DM + IPO group.
Table 1: Changes in body weight and fasting blood glucose of
control and diabetic rats before and after 12 weeks of STZ or vehicle
injection.
Normal Diabetes
0W 12W 0W 12W
Body
weight (g) 239.5 ± 7.4 418.7 ± 15.0 235.2 ± 6.7 204.5 ± 7.2
∗∗∗
FBG
(mmol/L) 6.6 ± 1.1 7.5 ± 1.6 7.1 ± 1.2 25.7 ± 4.5
∗∗∗
All values are expressed as mean ± SD. ∗∗∗𝑃 < 0.001 versus normal rats 12
weeks later after STZ injection.
Multiple Comparison Test. A value of 𝑃 < 0.05 was
considered to be statistically significant for all the statistical
tests.
3. Results
3.1. General Characteristics of STZ-Induced Diabetic Rats.
The general characteristics of diabetic compared with age-
matched control rats are shown in Table 1. Before STZ
induced diabetes, the body weight and fasting blood glu-
cose (FBG) were recorded and no significant evidence was
observed between the control and the intervention (𝑃 > 0.05,
Table 1).
During raising animal, we can observe that with a longer
duration of diabetes, the diabetic rats were bald and showed
polydipsia, polyuria, and weight loss. After feeding for 12
weeks, diabetic rats had remarkably lower body weight and
higher blood glucose compared to the age-matched controls
with euglycemia and a moderate growth rate at 5–10 g/d in
normal group (𝑃 < 0.001, Table 1).
3.2. The Difference of Myocardial Infarcted Area between
Normal and Diabetic Rats. To examine the different effect
of cardioprotective postconditioning on the normal and
diabetic hearts, myocardial infarcted area was measured.The
representative images of AAR and IA from each group were
shown in Figure 1. No more significant difference was shown
in the size of area at risk (AAR/LV) among the four groups
(Figure 1(a)). The infarct size in normal rats remarkably
decreased with the protective effect of postconditioning (𝑃 <
0.05, Figure 1(b)). Interestingly, the diabetic heart showsmore
extensive infracted area percentage (IA/AAR) than normal
heart when it suffers from the same degree of MI/R insult
(𝑃 < 0.05, Figure 1(b)), and the cardioprotective effect
of postconditioning was abolished since the infracted area
percentage (IA/AAR) in DM + IPO group was similar to
DM + IR group. These results provided that diabetic heart
was more vulnerable to MI/R, and postconditioning cannot
reverse the injury.
3.3. The Difference of Reactive Oxygen Species Level between
Normal and Diabetic Rats. Data are shown in Figure 2.
Compared with the N + S group, the IR induced injury was
manifested by a remarkable decrease in SOD and T-AOC,
associate with an increase in MDA and 15-F
2t-Isoprostane.
The ischemic postconditioning caused a significant reversion
of MI/R in normal rats. The diabetic rats got lower activity in
SOD and the level of MDA, T-AOC and 15-F
2t-Isoprostane
in diabetic rats is significantly higher than normal rats.
After subject to IR injury the activity of SOD losses mount
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Figure 2: Index of oxidative stress in different groups was analyzed by ANOVA. (a) The level of Total Antioxidant Capacity (T-AOC). (b)
The activity of Superoxide Dismutase (SOD). (c)The level of Malondialdehyde (MDA). (d)The level 15-F
2t-Isoprostane. Values presented are
mean ± SD (𝑛 = 6 each). 󳵳𝑃 < 0.05 & 󳵳󳵳𝑃 < 0.01 versus N + S group; ∗𝑃 < 0.05 & ∗∗𝑃 < 0.01 versus respective sham group #𝑃 < 0.05
versus respective IR group.
in diabetic rats. Meanwhile the increasing level of MDA,
T-AOC, and 15-F
2t-Isoprostane in DM + IR group was
aggravated. Unfortunately, ischemic postconditioning cannot
restore the MI/R injury in diabetic rats.
3.4. The Difference of DJ-1 Expression between Normal and
Diabetic Rats. It has been reported that DJ-1 is an antiox-
idative protein in ischemic brain injury [8]. To further
investigate the different effect of postconditioning on normal
anddiabetic hearts, we attempted to determine the expression
of DJ-1. As shown in Figure 3, the expression of DJ-1 was
abolished by diabetes mellitus, when compared with the
normal hearts and diabetic hearts, and this difference is not
likely to occur by chance (𝑃 < 0.01).
3.5. Variation of DJ-1 and Related Signal Transduction
Molecules in PI3K/Akt Signal Pathway during MI/R and IPost
in Normal and Diabetic Rats. Based on the recent studies in
other system, DJ-1 may act as antioxidant agents associated
with the regulation of PTEN and PI3K/Akt pathways [10],
which are considered as important signaling systems involved
in cardioprotection; thus, we investigated the expression of
DJ-1 and related signal transduction molecules during MI/R
and ischemic postconditioning in normal and diabetic rats.
As shown in Figure 4(b), expression of DJ-1 in N + IR
group was significantly higher than in N + S group (𝑃 <
0.01), and ischemic postconditioning further amplificated the
increment between the N + IR group and N + IPO group
(𝑃 < 0.001). However, when the same strike occurred in
diabetic rats, no significant changes were identified in DJ-
1 between DM + S group and DM + IR group (𝑃 > 0.05).
In addition, the expression of DJ-1 was abolished by diabetes
mellitus during ischemic postconditioning and no significant
change was observed between DM + IR group and DM +
IPO group (𝑃 > 0.05). The expression of PTEN was higher
during MI/R (𝑃 < 0.01) and then inhibited when ischemic
postconditioning aroused the level of DJ-1 in normal rats
(𝑃 < 0.05). Furthermore, we also observed a high level of
expression in MI/R in diabetic heart (𝑃 < 0.001) and drove
the Akt activation at a significantly lower level (𝑃 < 0.05) due
to the dysfunction of DJ-1, even ischemic postconditioning
can never reverse (Figures 4(c) and 4(d)). As shown in
Figure 4(e), no variation of total Akt was recorded in all
groups (𝑃 > 0.05).
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Figure 3: Effects of Diabetes Mellitus on the protein expression of
DJ-1. There were three different normal blank control rats (on the
left side) and three different diabetic blank control rats (on the right
side). All values are expressed asmean± SD (𝑛 = 6 each). ∗∗𝑃 < 0.01
versus normal rats.
3.6. The Relationship between DJ-1 and Myocardial Infarcted
Area, Phospho-Akt. Group differences in the relationship of
DJ-1 expression and the myocardial injury indexes were eval-
uatedwith simple linear regression (Figure 5).The expression
of DJ-1 was positively correlated with p-Akt with 𝑟2 at 0.6331
(𝑃 < 0.001), while myocardial infarct size was negatively
correlated with DJ-1; the corresponding 𝑟2 was 0.6354 (𝑃 <
0.001). These results suggest that DJ-1 may be endowed with
a salutary role in cardioprotection.
4. Discussion
We present several important observations from our study
supporting the beneficial function of DJ-1 in myocardial
defense against ROS. First, using in vivomodels of MI/R, we
demonstrated that the effectiveness of ischemic postcondi-
tioning asmeans ofmyocardial protectionmay closely related
to the level of myocardial DJ-1. Second, to our knowledge,
we are the first to report that the cardiac expression of DJ-1
was seriously inhibited in DM condition. Third, unlike the
change of DJ-1 expression level in the normal rat, neither
the compensatory increase of DJ-1 in response to the MI/R
insult nor the protective increment in response to ischemic
postconditioning was observed in diabetic condition.
In the present study, ischemic postconditioning reduced
myocardial infarction size and oxidative stress level, which
was intensely associated with enhanced expression of cardiac
DJ-1. Our results are well in line with finding of other
researches in kidney and brain [8, 11, 12]. Moreover, Lu et al.
have recently demonstrated that hypoxic preconditioning
upregulates DJ-1 protein expression in rat heart-derived
H9C2 cells which contributes to the cardioprotection against
hypoxia/reoxygenation injury [13]. Several lines of evidence
suggest that overexpression of DJ-1 may have a crucial role
against oxidative stress in ischemia/reperfusion (I/R)models.
Regarding the increase in the expression of DJ-1 in normal
MI/R group, we conjecture that it may be a compensatory
increase during the MI/R injury.
It has been revealed that a reduction of antioxidative
capacity in DJ-1 knock-out rats and mice in vivo and in vitro
[14–16]. In our study we also exhibited a decline of T-AOC
and SOD together with the increase of MDA and 15-F
2t in
diabetic rats which may be due to the downregulation of
DJ-1. Apart from the direct decreased expression of DJ-1,
another possibility that may account for the exacerbation of
oxidative stress was the peroxidation inactivation of DJ-1.
Meulener and his colleagues [17] demonstrated that human
DJ-1 (hDJ-1) rescues flies mutant for DJ-1b, and cysteine
residue in the fly DJ-1 (C104) is analogous to C106 in hDJ-
1. It has been confirmed in other studies that, the conserved
cysteine residue in DJ-1 (Cys106) was both essential for DJ-1
protective function and was sensitive to oxidation [18]. It was
supposed that the C104 subunit of DJ-1b was overoxidized
in chemical toxin or aged condition, which resulted in the
failure of dimerization and inactivation [17], similar to the
one occurred in diabetic status in our study. Thus, the
oxidative stress was further aggrandized due to the reduced
activation of DJ-1 and consequently weakened antioxidative
effect.
In the present study, the infarct size and oxidative
stress were more extensive in diabetic rat hearts than in
normal rats when endured the equivalent extent of ischemic
reperfusion insult. The peroxidative inactivation of DJ-1
caused by excessive ROS will facilitate ROS overproduction
in diabetes, which may predispose to a hypersensitivity of
diabeticmyocardium to ischemia and reperfusion in a vicious
circle manner.
Despite the emphasis on the impact of the duration of the
diabetic state, metabolic disturbance, more extensive lesions
(include atherosclerosis and hypertrophied), left ventricle
dysfunction on myocardial injury in diabetes [19–22], and
a number of studies which were carried out to investigate
the myocardial protective signaling disrupted by diabetes
have also been advocated [23, 24]. From data presented
in the literature, two signal pathways have contributed to
myocardial protection, one is Survivor Activating Factor
Enhancement (SAFE) pathway and the other is Reperfusion
Injury Salvage Kinase (RISK) pathway, which encompasses
PI3K/AKT and ERK 1/2. Activation of PI3K/AKT pathway
is responsible for protecting the myocardium by regulating
essential cellular functions, such as cell migration, cell sur-
vival, and modulating several essential biologic processes,
such as metabolism [25]. Furthermore, insulin activation
of the PI3K/AKT pathway has been shown to delay the
time to mitochondrial permeability transition pore (mPTP)
opening and reduce ROS level [26]. Therefore, any strategy
to activate PI3K/Akt and enlarge the threshold to mPTP
opening may provide the protective effect against myocardial
ischemia/reperfusion injuries.
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Figure 4: Immunoblot and densitometry analysis of the protein expression of DJ-1, PTEN, phosphorylated, and total Akt in normal and
diabetic myocardial tissue. GAPDHwas set as a loading control. Data are the mean ± SD (𝑛 = 6 each). (a)Western blot of DJ-1, PTEN, p-Akt,
total Akt, and GAPDH. (b) Statistical analysis of DJ-1 among different groups. (c) Statistical analysis of PTEN among different groups. (d)
Statistical analysis of p-Akt among different groups. (e) Statistical analysis of total Akt among different groups. 󳵳𝑃 < 0.05& 󳵳󳵳𝑃 < 0.01 versus
N + S group; ∗𝑃 < 0.05 & ∗∗𝑃 < 0.01 & ∗∗∗𝑃 < 0.001 versus respective sham group; #𝑃 < 0.05 versus respective IR group; ###𝑃 < 0.001
versus respective IR group.
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Figure 5: Simple linear regression between DJ-1 and myocardial infarct size together with p-Akt. (a) Linear regression between DJ-1 and
IA/AAR. (b) Linear regression between DJ-1 and p-Akt.
Despite that DJ-1 expression would be upregulated under
myocardial ischemia and reperfusion injury, it was not
enough to resist myocardial insult resulted from ischemia
reperfusion, while postconditioning may add to an endoge-
nous activation of the RISK pathway which enhances the
antioxidative effects of DJ-1. However, chronic oxidation
under DM may attenuate the expression of DJ-1 and the
underlying RISK pathway may also be partially inactivated;
thus, myocardial DJ-1 could not be stimulated under IR and
subsequently the responsiveness to postconditioning could
be attenuated or diminished.
Several studies have demonstrated that DJ-1 robustly
protects cells from oxidative stress through distinct cellular
pathways [27, 28]. In normal rats, ischemic postconditioning
can arouse DJ-1 high expression and confer myocardial
protection. Base on a series of studies on cancer cells, Kim
et al. [10] found that DJ-1 functions in the PI3K/Akt (RISK)
pathway as a negative regulator of PTEN. These results are
in good agreement with ours. In the normal rats, ischemic
postconditioning increased myocardial expression of DJ-1,
paralleled with decreased expression of PTEN as well as
increased Akt phosphorylation, and protected heart from
MI/R, while in diabetic rats, DJ-1 expression was inhibited
due to the overoxidation cause by DM. Therefore, ischemic
postconditioning cannot reverse the DJ-1 expression in dia-
betic rats. As a result, the expression of PTEN highly grows
unchecked and arrest PI3K/Akt (RISK) pathway functions.
These fatal change lead to a reduction in the threshold
and triggering mitochondrial permeability transition pore
(mPTP) opening in response to Ca2+ overload and break
the delicate balance between ROS production and scavenging
capacity of antioxidant systems. Given the deficiency of
agonist and antagonist of DJ-1, a better understanding of
the interaction between DJ-1 and ischemia postconditioning
protection could only be achieved by simple-linear regres-
sion; thus, further silencing and overexpression of DJ-1 via
genetic engineering would be needed, which could add to
a further comprehension of the underlying mechanism and
may provide a promising alternative in the prevention and
treatment of cardiovascular disease with DM.
5. Conclusion
With the result of in vitro study, we demonstrated the possible
correlation between inhibition of DJ-1 induced by hyper-
glycemia and ineffectiveness of postconditioning in diabetic
rats and that PI3K/Akt signal pathway may be one of the
major factors involved in the protective effect of DJ-1, which
should be further elucidated by in vivo studies. Our research
revealed a potential curative role of DJ-1 in the treatment of
diabetic cardiac complication. Thus, therapeutics aiming at
upregulating DJ-1 could be considered as a novel alternative
to alleviate the reperfusion injury in diabetic patients with
ischemic heart disease.
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